Skip to main content
search

hhs drugs

By April 25, 2015Headlines

The HHS Office of Inspector General scolded CMS for failing to follow a prior recommendation on how to pay for infusion drugs, costing the program over $200 million.

https://oig.hhs.gov/oei/reports/oei-12-15-00110.pdf

Tags:

Related Posts

Headlines
February 6, 2024

Cano

Cano Health apparently cannot, as it declares bankruptcy due to too much debt.  Building primary…
Kevin Roche 0
Headlines
January 24, 2024

Turquoise

Turquoise health raises a fresh $30 million in capital for its price transparency platform, as…
Kevin Roche 0
Headlines
January 24, 2024

CAR-T safety

I am co-f0under of a company that manages cell and gene therapy for health plans.…
Kevin Roche 0

Leave a comment

Close Menu